Home » MedAlliance Earns CE Mark for Drug-Eluting Balloon
MedAlliance Earns CE Mark for Drug-Eluting Balloon
MedAlliance has received CE mark certification for its Selution SLR 014 PTCA, a sirolimus drug-eluting balloon for treating patients with coronary arterial disease.
Sirolimus is an immunosuppressive drug frequently used to prevent organ rejection after a kidney transplant. The new certification is for treatment of lesions and in-stent restenosis.
The drug-eluting balloon uses “micro reservoirs” composed of biodegradable polymer that is mixed with the drug to control its release.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May